$AZN 4 SEC Filings

Filed On	Filing
08 Oct 2026	Form 4: Sharma Mani, See remarks Received 2 shares as a grant or award ($320)
11 Sep 2026	Form 4: Sharma Mani, See Remarks Bought 20.233 shares ($3.25K) · Received 1 shares as a grant or award ($163)
07 Aug 2026	Form 4: Sharma Mani, SVP, Group Controller Received 2 shares as a grant or award ($327)
08 Jul 2026	Form 4: Sharma Mani, See Remarks Received 2 shares as a grant or award ($381)
16 Jun 2026	Form 4: Sharma Mani, See Remarks Received 1 shares as a grant or award ($180)
22 May 2026	Form 4: Sharma Mani, See Remarks Sold 11,893 shares ($2.21M)
08 May 2026	Form 4: Sharma Mani, See Remarks Received 1 shares as a grant or award ($196) · Received 1 shares as a grant or award ($186)
16 Mar 2021	Form 4: Astrazeneca Plc, 10% owner and 1 other · Viela Bio, Inc. Disposed of 14,650,334 shares (Tender Offer) ($776M)
07 Feb 2020	Form 4: Astrazeneca Plc, 10% owner and 1 other · Aevi Genomic Medicine, LLC Bought 12,946,900 shares
09 Oct 2019	Form 4: Astrazeneca Plc, 10% owner and 1 other · Viela Bio, Inc. Received 14,225,324 shares by conversion · Bought 425,000 shares ($8.08M)
24 Oct 2018	Form 4: Astrazeneca Plc, 10% owner and 1 other · PhaseBio Pharmaceuticals Inc Received 2,404,554 shares by conversion · Bought 600,000 shares ($3M) · Exercised 113,891 Warrants to Purchase Series C-1 Preferred Stock · 2 more
02 Oct 2018	Form 4: Astrazeneca Plc, 10% owner and 1 other · Entasis Therapeutics Holdings Inc. Received 1,918,185 shares by conversion · Bought 246,666 shares ($3.7M)
05 Dec 2017	Form 4: Astrazeneca Plc, 10% owner and 1 other · ALBIREO PHARMA, INC. Sold 500,000 shares ($10.7M)
14 Nov 2014	Form 4: Astrazeneca Plc, 10% owner and 1 other · Regulus Therapeutics Inc. Sold 2,000,000 shares ($34M)

Comments